Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Clayton

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Basic Research in Cardiology|May 26, 2021
Translation of experimental cardioprotective capability of P2Y<sub>12</sub> inhibitors into clinical outcome in patients with ST-elevation myocardial infarctionMarie V Hjortbak, Kevin K W Olesen, Jacob M Seefeldt, et al.
JACC. Heart Failure|June 2, 2018
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic CardiomyopathyDivaka Perera, Tim Clayton, Mark C Petrie, et al.
Heart (British Cardiac Society)|August 11, 2017
Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortalityHeerajnarain Bulluck, Raju Maiti, Bibhas Chakraborty, et al.
European Heart Journal Open|October 13, 2023
Exaggerated elastin turnover in young individuals with Marfan syndrome: new insights from the AIMS trialZaid Iskandar, Matthew Dodd, Jeffrey Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
The New England Journal of Medicine|October 6, 2015
Remote Ischemic Preconditioning and Outcomes of Cardiac SurgeryDerek J Hausenloy, Luciano Candilio, Richard Evans, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 27, 2023
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trialRajesh K Kharbanda, Alexander David Perkins, James Kennedy, et al.
Forensic Science International. Genetics|December 17, 2008
National recommendations of the Technical UK DNA working group on mixture interpretation for the NDNAD and for court going purposesPeter Gill, Rosalind M Brown, Martin Fairley, et al.
Circulation|June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Basic Research in Cardiology|May 26, 2021
Translation of experimental cardioprotective capability of P2Y<sub>12</sub> inhibitors into clinical outcome in patients with ST-elevation myocardial infarctionMarie V Hjortbak, Kevin K W Olesen, Jacob M Seefeldt, et al.
JACC. Heart Failure|June 2, 2018
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic CardiomyopathyDivaka Perera, Tim Clayton, Mark C Petrie, et al.
Heart (British Cardiac Society)|August 11, 2017
Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortalityHeerajnarain Bulluck, Raju Maiti, Bibhas Chakraborty, et al.
European Heart Journal Open|October 13, 2023
Exaggerated elastin turnover in young individuals with Marfan syndrome: new insights from the AIMS trialZaid Iskandar, Matthew Dodd, Jeffrey Huang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2015
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trialsJennifer Yu, Roxana Mehran, Tim Clayton, et al.
The New England Journal of Medicine|October 6, 2015
Remote Ischemic Preconditioning and Outcomes of Cardiac SurgeryDerek J Hausenloy, Luciano Candilio, Richard Evans, et al.
European Heart Journal|March 6, 2025
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysisMatthew Ryan, Mark C Petrie, Evangelos Kontopantelis, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 27, 2023
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trialRajesh K Kharbanda, Alexander David Perkins, James Kennedy, et al.
Forensic Science International. Genetics|December 17, 2008
National recommendations of the Technical UK DNA working group on mixture interpretation for the NDNAD and for court going purposesPeter Gill, Rosalind M Brown, Martin Fairley, et al.
Circulation|June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Pageof 11